Clinical Trials
16 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT06996249 2026-03-03
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Recruiting
NCT05812027 2025-11-17
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
Active not recruiting
NCT06605404 2025-08-14
Pan-tumor MRD Study
Paradigm Health
Recruiting
NCT05337163 2025-03-21
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT02410603 2021-07-21
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Mayo Clinic
Completed
NCT03695835 2020-07-22
NIRPA
Gary Onik MD
Completed
NCT01662635 2019-01-09
ALK
Instituto Nacional de Cancerologia de Mexico
Completed
NCT02980536 2018-07-11
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China
Berry Genomics Co., Ltd.
Unknown
NCT02370303 2018-03-21
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Mayo Clinic
Completed
NCT02422628 2016-12-14
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
National Taiwan University Hospital
Unknown
NCT02755337 2016-04-28
EVALUATE
Dr. Soetomo General Hospital
Unknown
NCT02738684 2016-04-14
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Southwest Hospital, China
Unknown
NCT00132704 2014-07-24
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Completed
NCT01271959 2012-10-05
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics
Terminated